HK1070109A1 - Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarringor fibrosis - Google Patents

Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarringor fibrosis

Info

Publication number
HK1070109A1
HK1070109A1 HK05103423A HK05103423A HK1070109A1 HK 1070109 A1 HK1070109 A1 HK 1070109A1 HK 05103423 A HK05103423 A HK 05103423A HK 05103423 A HK05103423 A HK 05103423A HK 1070109 A1 HK1070109 A1 HK 1070109A1
Authority
HK
Hong Kong
Prior art keywords
predisposition
development
fibrosis
inappropriate
scarringor
Prior art date
Application number
HK05103423A
Other languages
English (en)
Inventor
Ferguson Mark William James
Ollier William Ernest Royce
Bayat Ardeshir
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of HK1070109A1 publication Critical patent/HK1070109A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Saccharide Compounds (AREA)
HK05103423A 2002-04-30 2005-04-21 Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarringor fibrosis HK1070109A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0209812.7A GB0209812D0 (en) 2002-04-30 2002-04-30 Genetic testing
PCT/GB2003/001717 WO2003093506A2 (en) 2002-04-30 2003-04-23 Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarring or fibrosis

Publications (1)

Publication Number Publication Date
HK1070109A1 true HK1070109A1 (en) 2005-06-10

Family

ID=9935744

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05103423A HK1070109A1 (en) 2002-04-30 2005-04-21 Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarringor fibrosis

Country Status (12)

Country Link
US (1) US20050239071A1 (de)
EP (1) EP1520039B1 (de)
JP (1) JP4384025B2 (de)
AT (1) ATE404696T1 (de)
AU (1) AU2003222980B2 (de)
CA (1) CA2482812A1 (de)
DE (1) DE60322901D1 (de)
DK (1) DK1520039T3 (de)
ES (1) ES2310239T3 (de)
GB (1) GB0209812D0 (de)
HK (1) HK1070109A1 (de)
WO (1) WO2003093506A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9928508B2 (en) 2000-08-04 2018-03-27 Intellectual Ventures I Llc Single sign-on for access to a central data repository
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
WO2004060278A2 (en) 2002-12-06 2004-07-22 Isis Pharmaceuticals, Inc. Methods for rapid identification of pathogens in humans and animals
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20040121309A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in blood, bodily fluids, and bodily tissues
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
JP5236286B2 (ja) * 2004-05-07 2013-07-17 セレラ コーポレーション 肝線維症に関連する遺伝的多型、その検出方法および使用
JP4810533B2 (ja) 2004-05-24 2011-11-09 アイビス バイオサイエンシズ インコーポレイティッド ディジタルスレショルド化による選択的イオン濾過作用を用いた質量分光測定法
US20050266411A1 (en) * 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
CA2600184A1 (en) 2005-03-03 2006-09-08 Isis Pharmaceuticals, Inc. Compositions for use in identification of adventitious viruses
US8026084B2 (en) 2005-07-21 2011-09-27 Ibis Biosciences, Inc. Methods for rapid identification and quantitation of nucleic acid variants
US8088582B2 (en) 2006-04-06 2012-01-03 Ibis Biosciences, Inc. Compositions for the use in identification of fungi
EP2064332B1 (de) 2006-09-14 2012-07-18 Ibis Biosciences, Inc. Gezielte gesamtgenomamplifizierung zur identifizierung von krankheitserregern
WO2008104002A2 (en) 2007-02-23 2008-08-28 Ibis Biosciences, Inc. Methods for rapid forensic dna analysis
WO2008151023A2 (en) 2007-06-01 2008-12-11 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
US8534447B2 (en) 2008-09-16 2013-09-17 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
WO2010033627A2 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
WO2010033599A2 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
US8158936B2 (en) 2009-02-12 2012-04-17 Ibis Biosciences, Inc. Ionization probe assemblies
US9719083B2 (en) 2009-03-08 2017-08-01 Ibis Biosciences, Inc. Bioagent detection methods
WO2010114842A1 (en) 2009-03-30 2010-10-07 Ibis Biosciences, Inc. Bioagent detection systems, devices, and methods
WO2011008972A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Systems for bioagent identification
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
US9416409B2 (en) 2009-07-31 2016-08-16 Ibis Biosciences, Inc. Capture primers and capture sequence linked solid supports for molecular diagnostic tests
EP3098325A1 (de) 2009-08-06 2016-11-30 Ibis Biosciences, Inc. Basenzusammensetzungen ohne massenbestimmung zur nukleinsäureerkennung
US9890408B2 (en) 2009-10-15 2018-02-13 Ibis Biosciences, Inc. Multiple displacement amplification
WO2011115840A2 (en) 2010-03-14 2011-09-22 Ibis Biosciences, Inc. Parasite detection via endosymbiont detection
FI20100211A0 (fi) * 2010-05-19 2010-05-19 Mas Metabolic Analytical Servi Menetelmä ateroskleroosialttiuden geneettiseksi diagnosoimiseksi
CN103981255B (zh) * 2014-04-01 2016-06-01 重庆医科大学附属儿童医院 一种Leber遗传性视神经病变体外诊断试剂盒
KR101651817B1 (ko) * 2015-10-28 2016-08-29 대한민국 Ngs 라이브러리 제작용 프라이머 세트 및 이를 이용한 ngs 라이브러리 제작방법 및 키트
KR102026138B1 (ko) * 2017-08-02 2019-09-27 충남대학교산학협력단 Crif1 억제제를 함유하는 켈로이드 및 비후성 반흔 형성 억제 또는 치료용 조성물
CN110221011A (zh) * 2019-05-22 2019-09-10 南京鼓楼医院 系统性硬化症诊断的脂肪酸代谢物分析检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273869A (en) * 1979-04-16 1981-06-16 The Regents Of The University Of Minnesota Cystic fibrosis detection method
SU1731489A1 (ru) * 1986-09-25 1992-05-07 Институт электроники им.У.А.Арифова Устройство дл электроэрозионной прошивки отверстий

Also Published As

Publication number Publication date
DE60322901D1 (de) 2008-09-25
WO2003093506A2 (en) 2003-11-13
ATE404696T1 (de) 2008-08-15
EP1520039B1 (de) 2008-08-13
WO2003093506A3 (en) 2004-03-11
EP1520039A2 (de) 2005-04-06
JP4384025B2 (ja) 2009-12-16
GB0209812D0 (en) 2002-06-05
DK1520039T3 (da) 2008-11-17
JP2005529592A (ja) 2005-10-06
CA2482812A1 (en) 2003-11-13
AU2003222980A1 (en) 2003-11-17
AU2003222980B2 (en) 2008-03-06
ES2310239T3 (es) 2009-01-01
US20050239071A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
HK1070109A1 (en) Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarringor fibrosis
Bonassi et al. Biomarkers in molecular epidemiology studies for health risk prediction
Broly et al. Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population
Suzuki et al. In a Vietnamese population, MSX1 variants contribute to cleft lip and palate
Blangero Localization and identification of human quantitative trait loci: king harvest has surely come
Buhule et al. Stratified randomization controls better for batch effects in 450K methylation analysis: a cautionary tale
MXPA04008477A (es) Metodos para deteccion de trastornos geneticos.
Chace et al. Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome
WO2007075836A3 (en) Methods for detection of genetic disorders
Kim et al. Chromosomal aberrations in workers exposed to low levels of benzene: association with genetic polymorphisms
WO2007147073A3 (en) Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
Shestak et al. Allelic dropout is a common phenomenon that reduces the diagnostic yield of PCR-based sequencing of targeted gene panels
Tsuchiya et al. Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19
Brancato et al. 8-Oxo-7, 8-dihydro-2′-deoxyguanosine and other lesions along the coding strand of the exon 5 of the tumour suppressor gene P53 in a breast cancer case-control study
Chen et al. Label-free fluorescent copper nanoclusters for genotyping of deletion and duplication of Duchenne muscular dystrophy
Park et al. Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities
Flossbach et al. High‐resolution genomic profiling reveals clonal evolution and competition in gastrointestinal marginal zone B‐cell lymphoma and its large cell variant
WO2010103292A3 (en) A genotyping tool for improving the prognostic and clinical management of ms patients
Ketelslegers et al. Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers
Kelada et al. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson’s disease
Damgaard et al. No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes
Ganda et al. A family-based association study of DNA sequence variants in GRM7 with schizophrenia in an Indonesian population
He et al. Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population
EP1676914A4 (de) Krankheit vom lymphomtyp und verfahren zur prognosebeurteilung
WO2006097463A3 (en) Compositions and methods for treating and diagnosing inflammatory disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120423